TRENTON: Johnson & Johnson has begun a research partnership to find the root cause of Type 1 diabetes and stop the hormonal disorder in its tracks. It’s the health care giant’s first project under its ambitious initiative to prevent or at least intercept and reduce harm from many diseases. In a collaboration with immunologist and …
The Germans Trias i Pujol Research Institute and the Catalan Institute for Nanoscience and Nanotechnology (ICN2) for the first time achieve to generate liposomes which imitate cells in the process of natural death. The research was published in PLOS ONE.
In silico experiments demonstrate that advanced sensor and software technology that improves the accuracy of Continuous Glucose Monitoring (CGM) can enable better detection of dangerously low blood sugar and reduced frequency of hypoglycemic episodes. The significance of this direct relationship between the accuracy of CGM and a reduction in hypoglycemia is explored in a Commentary published in Diabetes Technology & Therapeutics.
Intranasal glucagon can safely and effectively treat hypoglycemia in children with type 1 diabetes (T1D), according to new findings presented at the American Diabetes Association's annual meeting in Boston.
Led by professor Jeffery Tessem, four students with diabetes are investigating the molecular pathways that can activate the replication of beta cells. Beta cells are insulin-producing pancreas cells that are attacked and destroyed by the immune system of those with Type 1 diabetes.
A phase II clinical trial testing the ability of the generic BCG vaccine to reverse advanced type 1 diabetes has received approval from the US Food and Drug Administration. The trial to be led by Denise Faustman, M.D., Ph.D., director of the Massachusetts General Hospital Immunobiology Laboratory, will soon begin enrolling participants.
MiniMed 640G System Shown to Further Reduce Hypoglycemia; Pivotal Study to Examine Safety of Hybrid Closed Loop System for People with Diabetes BOSTON - June 6, 2015 - As part of its commitment to developing ...
(PRWEB) June 03, 2015 -- Addition of Insulin Pump & CGM data, used for intensive glucose management of Type 1 and Type 2 diabetes, enhances utility of Glooko’s remote monitoring and predictive glucose analytics tools for high-risk diabetes patients and their healthcare providers.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.